1. Home
  2. IMRX vs VNME Comparison

IMRX vs VNME Comparison

Compare IMRX & VNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRX
  • VNME
  • Stock Information
  • Founded
  • IMRX 2008
  • VNME 2025
  • Country
  • IMRX United States
  • VNME United States
  • Employees
  • IMRX N/A
  • VNME N/A
  • Industry
  • IMRX Biotechnology: Pharmaceutical Preparations
  • VNME Blank Checks
  • Sector
  • IMRX Health Care
  • VNME Finance
  • Exchange
  • IMRX Nasdaq
  • VNME Nasdaq
  • Market Cap
  • IMRX 232.9M
  • VNME 255.4M
  • IPO Year
  • IMRX 2021
  • VNME 2025
  • Fundamental
  • Price
  • IMRX $8.07
  • VNME $9.91
  • Analyst Decision
  • IMRX Strong Buy
  • VNME
  • Analyst Count
  • IMRX 4
  • VNME 0
  • Target Price
  • IMRX $13.75
  • VNME N/A
  • AVG Volume (30 Days)
  • IMRX 1.3M
  • VNME 154.5K
  • Earning Date
  • IMRX 11-12-2025
  • VNME 01-01-0001
  • Dividend Yield
  • IMRX N/A
  • VNME N/A
  • EPS Growth
  • IMRX N/A
  • VNME N/A
  • EPS
  • IMRX N/A
  • VNME N/A
  • Revenue
  • IMRX N/A
  • VNME N/A
  • Revenue This Year
  • IMRX N/A
  • VNME N/A
  • Revenue Next Year
  • IMRX N/A
  • VNME N/A
  • P/E Ratio
  • IMRX N/A
  • VNME N/A
  • Revenue Growth
  • IMRX N/A
  • VNME N/A
  • 52 Week Low
  • IMRX $1.10
  • VNME $9.89
  • 52 Week High
  • IMRX $9.37
  • VNME $9.95
  • Technical
  • Relative Strength Index (RSI)
  • IMRX 69.91
  • VNME N/A
  • Support Level
  • IMRX $7.82
  • VNME N/A
  • Resistance Level
  • IMRX $8.85
  • VNME N/A
  • Average True Range (ATR)
  • IMRX 0.75
  • VNME 0.00
  • MACD
  • IMRX 0.19
  • VNME 0.00
  • Stochastic Oscillator
  • IMRX 69.91
  • VNME 0.00

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

About VNME Vendome Acquisition Corporation I Class A Ordinary Shares

Vendome Acquisition Corp I is a blank check company.

Share on Social Networks: